Skip to main content
. 2021 Jul 23;15(3):78. doi: 10.3892/br.2021.1454

Table V.

Interaction of the TNF-α-308G/A polymorphism with clinical factors, as determined using multivariate logistic regression analysis.

Polymorphism Clinical factor IS patients, n=200 Controls, n=200 Adjusted OR (95% CI) P-value
TNF-α-308G/A Hypertension        
     GG No 42 110 1.000  
     GA+AA No 4 12 0.448 (0.133-1.513)c 0.196
     GG Yes 124 71 2.655 (1.721-4.094)c <0.001b
     GA+AA Yes 30 7 4.585 (1.892-11.110)c 0.001b
TNF-α-308G/A Hyperlipidemia        
     GG No 79 135 1.000  
     GA+AA No 15 14 1.291 (0.546-3.054)d 0.560
     GG Yes 87 46 2.253 (1.401-3.624)d 0.001b
     GA+AA Yes 19 5 3.016 (1.027-8.862)d 0.045a
TNF-α-308G/A Smoking        
     GG No 118 145 1.000  
     GA+AA No 25 16 1.466 (0.686-3.134)e 0.324
     GG Yes 48 36 1.404 (0.800-2.462)e 0.237
     GA+AA Yes 9 3 4.010 (0.889-18.092)e 0.071
TNF-α-308G/A Alcohol drinking        
     GG No 126 156 1.000  
     GA+AA No 30 18 1.650 (0.811-3.355)f 0.167
     GG Yes 40 25 1.934 (1.037-3.608)f 0.038a
     GA+AA Yes 4 1 2.721 (0.288-25.693)f 0.382

aP<0.05,

bP≤0.001. P-values were calculated using multivariate logistic regression analysis. The adjusted OR (95% CI) was calculated via multivariate logistic regression analysis after adjustment for

csex, age, diabetes mellitus, metabolic syndrome, hyperlipidemia, smoking and drinking;

dsex, age, diabetes mellitus, metabolic syndrome, hypertension, smoking and drinking;

esex, age, diabetes mellitus, metabolic syndrome, hypertension, hyperlipidemia and drinking;

fsex, age, diabetes mellitus, metabolic syndrome, hypertension, hyperlipidemia and smoking. IS, ischemic stroke; OR, odds ratio; CI, confidence interval.